Novo Nordisk Aktie
42,10
EUR
+0,35
EUR
+0,83
%
42,20
EUR
+0,38
EUR
+0,90
%
Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novo Nordisk Aktie Analyse
| 04.10.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 23.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.09.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.09.19 | Novo Nordisk Outperform | Bernstein Research | |
| 05.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 02.09.19 | Novo Nordisk buy | UBS AG | |
| 28.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.08.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 09.08.19 | Novo Nordisk buy | UBS AG | |
| 09.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 31.07.19 | Novo Nordisk buy | UBS AG | |
| 08.07.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.07.19 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 18.06.19 | Novo Nordisk buy | UBS AG | |
| 17.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.06.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 12.06.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.06.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 11.06.19 | Novo Nordisk buy | UBS AG | |
| 11.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.06.19 | Novo Nordisk Outperform | Bernstein Research | |
| 29.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.05.19 | Novo Nordisk buy | UBS AG | |
| 06.05.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.05.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 03.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.05.19 | Novo Nordisk buy | UBS AG | |
| 29.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.04.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 12.04.19 | Novo Nordisk Outperform | Bernstein Research | |
| 11.04.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.04.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 20.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 18.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.03.19 | Novo Nordisk Outperform | Bernstein Research | |
| 05.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.02.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 01.02.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
Werbung
Werbung